Literature DB >> 28243902

Human Umbilical Cord Blood Serum: Effective Substitute of Fetal Bovine Serum for Culturing of Human Multipotent Mesenchymal Stromal Cells.

Yu A Romanov1,2, E E Balashova3,4, N E Volgina5, N V Kabaeva3, T N Dugina4, G T Sukhikh5.   

Abstract

Optimal conditions for culturing of multipotent mesenchymal stromal cells in the presence of pooled umbilical cord blood serum were determined. It was found that umbilical cord blood serum in a concentration range of 1-10% effectively supported high viability and proliferative activity of cells with unaltered phenotype and preserved multilineage differentiation capacity. The proposed approach allows avoiding the use of xenogenic animal sera for culturing of multipotent mesenchymal stromal cells and creates prerequisites for designing and manufacturing safe cellular and/or acellular products for medical purposes.

Entities:  

Keywords:  differentiation; multipotent mesenchymal stromal cells; phenotype; proliferation; umbilical cord blood serum

Mesh:

Substances:

Year:  2017        PMID: 28243902     DOI: 10.1007/s10517-017-3654-9

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  3 in total

1.  Cord blood serum harvesting by hydroxyethyl starch: a fetal bovine serum alternative in expansion of umbilical cord-derived mesenchymal stem cells.

Authors:  Maryam Samareh Salavati Pour; Reza Vahidi; Mahla Lashkari; Ali Derakhshani; Zahra Ameri; Alireza Farsinejad
Journal:  Cytotechnology       Date:  2020-06-29       Impact factor: 2.058

2.  Cord blood-derived platelet concentrates as starting material for new therapeutic blood components prepared in a public cord blood bank: from product development to clinical application.

Authors:  Dinara Samarkanova; Luciano Rodríguez; Joaquim Vives; Ruth Coll; Elisabet Tahull; Carmen Azqueta; Elena Valdivia; Margarita Codinach; Elisenda Farssac; Jesus Gaitan; Jose R Escudero; Sergio Querol
Journal:  Blood Transfus       Date:  2020-04-03       Impact factor: 3.443

3.  Umbilical cord blood plasma-derived exosomes as a novel therapy to reverse liver fibrosis.

Authors:  Yu-Jen Huang; Jerry Cao; Chih-Yuan Lee; Yao-Ming Wu
Journal:  Stem Cell Res Ther       Date:  2021-11-12       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.